×
About 10,732 results

ALLMedicine™ Edema Center

Research & Reviews  5,073 results

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therap...
https://doi.org/10.1089/jop.2021.0001
Journal of Ocular Pharmacology and Therapeutics : the Off... Gelfman CM, Grishanin R et. al.

Apr 9th, 2021 - Inhibition of vascular endothelial growth factor is the mode of action for several approved therapies, including aflibercept, for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Lack of compli...

A Swept source optical coherence tomography angiography study: Imaging artifacts and co...
https://doi.org/10.1371/journal.pone.0249918
PloS One; Podkowinski D, Beka S et. al.

Apr 8th, 2021 - Swept Source Optical coherence tomography angiography (SS-OCTA) is a novel technique to visualize perfusion and vascular changes like ischemia in patients with diabetic retinopathy. The aim of this study was to compare non-perfusion areas on conve...

Detection of bone marrow edema in osteonecrosis of the femoral head using virtual nonca...
https://doi.org/10.1016/j.ejrad.2021.109681
European Journal of Radiology; Zuo T, Chen Y et. al.

Apr 5th, 2021 - To determine the diagnostic performance of virtual noncalcium (VNCa) dual-energy computed tomography (DECT) in the detection of bone marrow edema (BME) in participants with osteonecrosis of the femoral head (ONFH). In this prospective study, 24 co...

Panretinal photocoagulation after or prior to intravitreal conbercept injection for dia...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015169
BMC Ophthalmology; Zhang W, Zhao G et. al.

Apr 1st, 2021 - Panretinal photocoagulation treatment (PRP) have been known as a standard treatment for proliferative diabetic retinopathy (PDR) or severe nonproliferative diabetic retinopathy (sNPDR). However, there is no consensus on when PRP should be administ...

see more →

Guidelines  5 results

Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema.
https://doi.org/10.3928/23258160-20160224-01
Ophthalmic Surgery, Lasers & Imaging Retina; Puliafito CA, Cousins SW et. al.

Apr 20th, 2016 - The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has grown. Since 2012, four pharmacotherapies have been approved by the U.S. Food and Drug Administration for the treatment of DME. First...

Recommendations for the appropriate management of diabetic macular edema: Light on DME ...
https://doi.org/10.5301/ejo.5000736
European Journal of Ophthalmology; Bandello F, Midena E et. al.

Jan 18th, 2016 - The Light on DME survey was designed to address several issues concerning the management of diabetic macular edema (DME) with the objective of producing practical recommendations for the appropriate treatment of this condition. The recommendations...

Management paradigms for diabetic macular edema.
https://doi.org/10.1016/j.ajo.2013.11.012
American Journal of Ophthalmology; Mitchell P, Wong TY et. al.

Nov 25th, 2013 - To provide evidence-based recommendations for diabetic macular edema (DME) management based on updated information from publications on DME treatment modalities. Perspective. A literature search for "diabetic macular edema" or "diabetic maculopath...

Rationale for the diabetic retinopathy clinical research network treatment protocol for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253487
Ophthalmology , et. al.

Dec 5th, 2011 - To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) in a Diabetic Retinopathy Clinical Research N...

Wilderness Medical Society consensus guidelines for the prevention and treatment of acu...
https://doi.org/10.1016/j.wem.2010.03.002
Wilderness & Environmental Medicine; Luks AM, McIntosh SE et. al.

Jul 1st, 2010 - To provide guidance to clinicians about best practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for the prevention and treatment of acute mountain sickness (AMS), high altitude cerebral ed...

see more →

Drugs  21 results see all →

Clinicaltrials.gov  5,361 results

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therap...
https://doi.org/10.1089/jop.2021.0001
Journal of Ocular Pharmacology and Therapeutics : the Off... Gelfman CM, Grishanin R et. al.

Apr 9th, 2021 - Inhibition of vascular endothelial growth factor is the mode of action for several approved therapies, including aflibercept, for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Lack of compli...

A Swept source optical coherence tomography angiography study: Imaging artifacts and co...
https://doi.org/10.1371/journal.pone.0249918
PloS One; Podkowinski D, Beka S et. al.

Apr 8th, 2021 - Swept Source Optical coherence tomography angiography (SS-OCTA) is a novel technique to visualize perfusion and vascular changes like ischemia in patients with diabetic retinopathy. The aim of this study was to compare non-perfusion areas on conve...

Detection of bone marrow edema in osteonecrosis of the femoral head using virtual nonca...
https://doi.org/10.1016/j.ejrad.2021.109681
European Journal of Radiology; Zuo T, Chen Y et. al.

Apr 5th, 2021 - To determine the diagnostic performance of virtual noncalcium (VNCa) dual-energy computed tomography (DECT) in the detection of bone marrow edema (BME) in participants with osteonecrosis of the femoral head (ONFH). In this prospective study, 24 co...

Panretinal photocoagulation after or prior to intravitreal conbercept injection for dia...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015169
BMC Ophthalmology; Zhang W, Zhao G et. al.

Apr 1st, 2021 - Panretinal photocoagulation treatment (PRP) have been known as a standard treatment for proliferative diabetic retinopathy (PDR) or severe nonproliferative diabetic retinopathy (sNPDR). However, there is no consensus on when PRP should be administ...

Fenortho - isatuximab injection, solution, concentrate-sanof-aventis U.S. LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0473462-6f9d-4eca-a5bf-8620aea68e8a

Mar 31st, 2021 - Boxed Warning 4/2016 Warnings and Precautions, Cardiovascular Thrombotic Events ( 5.1) 4/2016 Warnings and Precautions, Heart Failure and Edema ( 5.5) 4/2016

see more →

News  259 results

Positive Topline Data for Lilly's Donanemab in Early Alzheimer's
https://www.medscape.com/viewarticle/943905

Jan 10th, 2021 - Donanemab (Eli Lilly), an investigational antiamyloid therapy, significantly slowed decline in a composite measure of cognition and daily function in patients with early symptomatic Alzheimer's disease (AD) in the phase 2 TRAILBLAZER-ALZ study, th...

Dexamethasone May Curb Efficacy of Immune Checkpoint Blockade in Glioblastoma
https://www.medscape.com/viewarticle/941951

Dec 3rd, 2020 - NEW YORK (Reuters Health) - Dexamethasone given to combat cerebral edema in patients with glioblastoma may negatively affect immunotherapy, according to work in mice and clinical data. "There are many biologic, endogenous factors contributing to i...

Fluocinolone Implant Real-World Experience Matches DME Trials
https://www.medscape.com/viewarticle/941084

Nov 15th, 2020 - A fluocinolone acetonide implant (Iluvien) administered under real-world circumstances works just as well for diabetic macular edema (DME) as it did in clinical trials, a new study suggests. Patients who had not benefited from anti-vascular endoth...

Diabetic Macular Edema in Black Patients Less Responsive to Bevacizumab
https://www.staging.medscape.com/viewarticle/940075

Nov 1st, 2020 - NEW YORK (Reuters Health) - Black patients with diabetic macular edema (DME) are half as likely as their white or Hispanic peers to show short-term improvement in visual acuity after bevacizumab treatment, new findings show. About a third of Black...

Diabetic Macular Edema in Black Patients Less Responsive to Bevacizumab
https://www.medscape.com/viewarticle/940075

Nov 1st, 2020 - NEW YORK (Reuters Health) - Black patients with diabetic macular edema (DME) are half as likely as their white or Hispanic peers to show short-term improvement in visual acuity after bevacizumab treatment, new findings show. About a third of Black...

see more →

Patient Education  13 results see all →